Adjuvant chemotherapy in elderly patients: An analysis of national cancer institute of Canada clinical trials group and intergroup JBR.10

被引：0
|
作者：
Pepe, C.
Hasan, B.
Winton, T.
Seymour, L.
Pater, J.
Livingston, R.
Johnson, D.
Rigas, J.
Ding, K.
Shepherd, F. A.
机构：
来源：
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | 2006年 / 60卷
关键词：
D O I：
10.1016/S1040-8428(13)70021-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S6 / S7
页数：2
相关论文
共 50 条
  • [41] Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of The National Cancer Institute of Canada Clinical Trials Group
    Osoba, D
    Beziak, A
    Brundage, M
    Zee, B
    Tu, DS
    Pater, J
    EUROPEAN JOURNAL OF CANCER, 2005, 41 (02) : 280 - 287
  • [42] A randomized placebo-controlled study of tamoxifen after adjuvant chemotherapy in premenopausal women with early breast cancer (National Cancer Institute of Canada-Clinical Trials Group Trial, MA.12)
    Bramwell, V. H. C.
    Pritchard, K. I.
    Tu, D.
    Tonkin, K.
    Vachhrajani, H.
    Vandenberg, T. A.
    Robert, J.
    Arnold, A.
    O'Reilly, S. E.
    Graham, B.
    Shepherd, L.
    ANNALS OF ONCOLOGY, 2010, 21 (02) : 283 - 290
  • [43] Immunohistochemical validation study of 15-gene biomarker panel predictive of benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of JBR.10
    Grieve, Stacy
    Ding, Keyue
    Moore, Jonathan
    Finniss, Mathew
    Ray, Ayush
    Lees, Miranda
    Hossain, Faisal
    Murugesan, Alli
    Agar, Jane
    Acar, Cenk
    Taylor, James
    Shepherd, Frances A.
    Reiman, Tony
    ESMO OPEN, 2020, 5 (02)
  • [44] Current Academic Clinical Trials in Ovarian Cancer Gynecologic Cancer Intergroup and US National Cancer Institute Clinical Trials Planning Meeting, May 2009
    Trimble, Edward L.
    Birrer, Michael J.
    Hoskins, William J.
    Marth, Christian
    Petryshyn, Ray
    Quinn, Michael
    Thomas, Gillian M.
    Kitchener, Henry C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2010, 20 (07) : 1284 - 1298
  • [45] The Influence of Sex on Efficacy, Adverse Events, Quality of Life, and Delivery of Treatment in National Cancer Institute of Canada Clinical Trials Group Non-small Cell Lung Cancer Chemotherapy Trials
    Wheatley-Price, Paul
    Le Maitre, Aurelie
    Ding, Keyue
    Leighl, Natasha
    Hirsh, Vera
    Seymour, Lesley
    Bezjak, Andrea
    Shepherd, Frances A.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : 640 - 648
  • [46] The influence of sex on efficacy, toxicity and delivery of treatment in National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) non-small cell lung cancer (NSCLC) chemotherapy trials
    Wheatley-Price, P.
    Le Maitre, A.
    Ding, K.
    Leighl, N. B.
    Hirsh, V.
    Seymour, L.
    Shepherd, F. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [47] National Cancer Institute Working Group proposes restructuring clinical trials network
    不详
    JOURNAL OF INVESTIGATIVE MEDICINE, 2005, 53 (03) : 109 - 109
  • [48] PHASE-II STUDY OF MITOXANTRONE IN PATIENTS WITH MESOTHELIOMA - A NATIONAL-CANCER-INSTITUTE-OF-CANADA CLINICAL-TRIALS GROUP-STUDY
    EISENHAUER, EA
    EVANS, WK
    RAGHAVAN, D
    DESMEULES, MJ
    MURRAY, NR
    STUARTHARRIS, R
    WILSON, KS
    CANCER TREATMENT REPORTS, 1986, 70 (08): : 1029 - 1030
  • [49] Bortezomib is active in patients with untreated or relapsed Waldenstrom's macroglobulinemia: A phase II study of the National Cancer Institute of Canada Clinical Trials Group
    Chen, Christine I.
    Kouroukis, C. Tom
    White, Darrell
    Voralia, Michael
    Stadtmauer, Edward
    Stewart, A. Keith
    Wright, John J.
    Powers, Jean
    Walsh, Wendy
    Eisenhauer, Elizabeth
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (12) : 1570 - 1575
  • [50] Phase 2 study of T138067-sodium in patients with malignant glioma: Trial of the National Cancer Institute of Canada clinical trials group
    Kirby, S
    Gertler, SZ
    Mason, W
    Watling, C
    Forsyth, P
    Aniagolu, J
    Stagg, R
    Wright, M
    Powers, J
    Eisenhauer, EA
    NEURO-ONCOLOGY, 2005, 7 (02) : 183 - 188
12345